Price $144.40 |
Market Cap
9.53B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
23.6
|
P/B
4.73
|
P/S
6.14
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
22.0
|
Op. Cash Flow
611.4K
|
FCF
7.1
|
|
Op. Margin
39.70%
|
Net Margin
26.80%
|
ROE
22.50%
|
ROI
11.70%
|
|
ROA
9.10%
|
EPS Growth
24.60%
|
Current Ratio
2.9
|
Debt/Equity
106.20%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Xtant Medical Holdings Inc (XTNT) | $0.65 | - | - | 13.5M | Strong Buy |
| Endo International PLC (ENDP) | $8.72 | - | - | 2.49B | Strong Buy |
| Encision Inc (ECIA) | $0.43 | - | - | 4.4M | Strong Buy |
| Invo Bioscience Inc (IVOB) | $0.22 | - | - | 31.1M | Strong Buy |
| CV Sciences Inc (CVSI) | $0.23 | - | - | 22.8M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
